Ocugen Company
Ocugen is a clinical stage biopharmaceutical company.
Founded Date:
2013
Last Funding Type:
Seed
Headquarters:
Malvern, Pennsylvania, United States
Investors Number:
2
Technology:
Others
Employee Number:
11-50
Industry:
Gene Therapy
Estimated Revenue:
$1M to $10M
Funding Status:
IPO
Investor Type:
For Profit